Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 53 citing articles:

Glioblastoma and Other Primary Brain Malignancies in Adults
Lauren Schaff, Ingo K. Mellinghoff
JAMA (2023) Vol. 329, Iss. 7, pp. 574-574
Closed Access | Times Cited: 514
Qualifying antibodies for image-based immune profiling and multiplexed tissue imaging
Ziming Du, Jia‐Ren Lin, Rumana Rashid, et al.
Nature Protocols (2019) Vol. 14, Iss. 10, pp. 2900-2930
Open Access | Times Cited: 120
Meningioma: A Review of Clinicopathological and Molecular Aspects
Kristin Huntoon, Angus Toland, Sonika Dahiya
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 114
Molecular alterations in meningioma: prognostic and therapeutic perspectives
Cristina Birzu, Matthieu Peyre, Felix Sahm
Current Opinion in Oncology (2020) Vol. 32, Iss. 6, pp. 613-622
Closed Access | Times Cited: 72
Phase 2 study of pembrolizumab in patients with recurrent and residual high-grade meningiomas
Priscilla K. Brastianos, Albert E. Kim, Anita Giobbie‐Hurder, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 62
Activity of PD-1 blockade with nivolumab among patients with recurrent atypical/anaplastic meningioma: phase II trial results
Wenya Linda Bi, Lakshmi Nayak, David M. Meredith, et al.
Neuro-Oncology (2021) Vol. 24, Iss. 1, pp. 101-113
Open Access | Times Cited: 61
The medical necessity of advanced molecular testing in the diagnosis and treatment of brain tumor patients
Craig Horbinski, Keith L. Ligon, Priscilla K. Brastianos, et al.
Neuro-Oncology (2019) Vol. 21, Iss. 12, pp. 1498-1508
Open Access | Times Cited: 55
Recent Advances in Meningioma Immunogenetics
May Alrashed, Kara M. Foshay, Malak Abedalthagafi
Frontiers in Oncology (2020) Vol. 9
Open Access | Times Cited: 55
Targeting the CSF1/CSF1R axis is a potential treatment strategy for malignant meningiomas
Jacky T. Yeung, Vesal Yaghoobi, Danielle Miyagishima, et al.
Neuro-Oncology (2021) Vol. 23, Iss. 11, pp. 1922-1935
Open Access | Times Cited: 46
Highly multiplexed immunofluorescence images and single-cell data of immune markers in tonsil and lung cancer
Rumana Rashid, Giorgio Gaglia, Chen Yuan, et al.
Scientific Data (2019) Vol. 6, Iss. 1
Open Access | Times Cited: 48
Basis for Immunotherapy for Treatment of Meningiomas
Tomás Garzón-Muvdi, Destiny D. Bailey, Mark N. Pernik, et al.
Frontiers in Neurology (2020) Vol. 11
Open Access | Times Cited: 41
Going to extremes: determinants of extraordinary response and survival in patients with cancer
Flurina A.M. Saner, Alan Herschtal, Brad H. Nelson, et al.
Nature reviews. Cancer (2019) Vol. 19, Iss. 6, pp. 339-348
Open Access | Times Cited: 42
T lymphocyte-targeted immune checkpoint modulation in glioma
William Kelly, Amber Giles, Mark R. Gilbert
Journal for ImmunoTherapy of Cancer (2020) Vol. 8, Iss. 1, pp. e000379-e000379
Open Access | Times Cited: 37
Molecular Profiling of 22 Primary Atypical Meningiomas Shows the Prognostic Significance of 18q Heterozygous Loss and CDKN2A/B Homozygous Deletion on Recurrence-Free Survival
Valeria Barresi, Michele Simbolo, Adele Fioravanzo, et al.
Cancers (2021) Vol. 13, Iss. 4, pp. 903-903
Open Access | Times Cited: 28
The Tumor Immune Microenvironment in Primary CNS Neoplasms: A Review of Current Knowledge and Therapeutic Approaches
Anita Kalluri, Pavan P. Shah, Michael Lim
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2020-2020
Open Access | Times Cited: 11
Case report: Clonal evolution analysis of a rare case of meningioma lung metastases identifies actionable alterations in matched longitudinal tumour samples
Nicola Cosgrove, Órla Fitzpatrick, Liam Grogan, et al.
Frontiers in Oncology (2025) Vol. 14
Open Access
Knowledge structures and research hotspots of immunotherapy for brain metastasis, glioma, meningioma, and pituitary adenoma: A bibliometric and visualization review
Donghu Yu, Jin Wang, Lei Hu, et al.
Chinese Chemical Letters (2025), pp. 110995-110995
Closed Access
Programmed death ligand-1 (PD-L1) expression in meningioma; prognostic significance and its association with hypoxia and NFKB2 expression
Shirin Karimi, Sheila Mansouri, Yasin Mamatjan, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 28
Novel Advances in Treatment of Meningiomas: Prognostic and Therapeutic Implications
Gerardo Caruso, Rosamaria Ferrarotto, Antonello Curcio, et al.
Cancers (2023) Vol. 15, Iss. 18, pp. 4521-4521
Open Access | Times Cited: 10
A narrative review of targeted therapies in meningioma
Lyndon Kim
Chinese Clinical Oncology (2020) Vol. 9, Iss. 6, pp. 76-76
Open Access | Times Cited: 27
Advances in Molecular Classification and Therapeutic Opportunities in Meningiomas
Christine Cordova, Sylvia C. Kurz
Current Oncology Reports (2020) Vol. 22, Iss. 8
Closed Access | Times Cited: 24
Chemotherapy and targeted therapies for meningiomas: what is the evidence?
Thomas Graillon, Émeline Tabouret, Olivier Chinot
Current Opinion in Neurology (2021) Vol. 34, Iss. 6, pp. 857-867
Closed Access | Times Cited: 23
Comparative genomic analysis of driver mutations in matched primary and recurrent meningiomas
Joshua Loewenstern, John W. Rutland, Corey M. Gill, et al.
Oncotarget (2019) Vol. 10, Iss. 37, pp. 3506-3517
Open Access | Times Cited: 24
Clinical significance of checkpoint regulator “Programmed death ligand-1 (PD-L1)” expression in meningioma: review of the current status
Shirin Karimi, Sheila Mansouri, Farshad Nassiri, et al.
Journal of Neuro-Oncology (2021) Vol. 151, Iss. 3, pp. 443-449
Open Access | Times Cited: 18
Response to immune checkpoint inhibition in a meningioma with DNA mismatch repair deficiency
Minh Nguyen, Damian A. Almiron Bonnin, Kanish Mirchia, et al.
Neuro-Oncology Advances (2024) Vol. 6, Iss. 1
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top